Genetically modified tumor-targeted bacteria with reduced virulence
Patent Information
- Authority / Receiving Office
- US ยท United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- YALE UNIV
- Publication Date
- 2002-02-28
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] This application is a continuation-in-part of application Ser. No. 08 / 926,636, filed Sep. 10, 1997, the entire disclosure of which is incorporated by reference herein in its entirety.1. FIELD OF THE INVENTION
[0002] The present invention is concerned with the isolation of a gene of Salmonella which, when genetically disrupted, reduces both virulence and septic shock caused by this organism and increases sensitivity to agents which promote eradication of the bacteria, e.g., chelating agents. The nucleotide sequence of this gene and the means for its genetic disruption are provided, and examples of the use of tumor-targeted bacteria which possess a disruption in this gene to inhibit growth of cancers, including, but not limited to, melanoma, colon cancer, and other solid tumors are described. The present invention also provides for the genetic disruption of this gene in combination with disruption of an auxotrophic gene.2. BACKGROUND OF THE INVENTION
[0003] Citation or identifica...